SRPT CLASS ACTION NEWS: Sarepta Therapeutics, Inc. Investors With Losses Are Notified of The Pending Securities Fraud Class Action – Contact BFA Law by August 25 Deadline
NEW YORK CITY, NY / ACCESS Newswire / August 5, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Sarepta Therapeutics, Inc. (NASDAQ:SRPT) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Sarepta, you are […]